GSK: 葛兰素史克

GSK新闻

• 18:53 GSK获美国FDA批准Blujepa作为淋病口服治疗药物
• 18:52 GSK receives US FDA approval for Blujepa as oral treatment for gonorrhoea
• 17:56 GSK的Blujepa获美国批准作为口服淋病治疗药物
• 17:55 GSK’s Blujepa approved as oral treatment for gonorrhoea in US
• 16:03 GSK's Risvutatug Rezetecan Gets FDA's Orphan Drug Tag in Lung Cancer
• 14:12 GSK Stock Up Almost 19% in 3 Months: Should You Buy, Hold or Sell?
• 13:31 施蒂菲尔下调AnaptysBio目标价至56美元，基于Jemperli销售前景
• 13:30 AnaptysBio stock price target lowered to $56 by Stifel on Jemperli sales outlook
• 14:40 Here's Why GSK (GSK) is a Strong Value Stock
• 13:06 HSBC highlights one pharma stock to buy and one to sell for 2026
• 07:12 GSK肺癌药物risvutatug rezetecan获FDA孤儿药资格认定
• 07:11 GSK’s lung cancer drug risvutatug rezetecan receives FDA orphan status
• 17:05 英国股市收低；截至收盘Investing.com 英国 100下跌0.04%
• 17:05 U.K. stocks lower at close of trade; Investing.com United Kingdom 100 down 0.04%
• 14:10 How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks
• 06:43 Novartis teams with UK biotech in $1.7 bln AI allergy drug deal – report
• 23:00 Nvidia, Palantir AWOL, But Top Funds Go Bonkers For This AI Mobilizer
• 18:35 Vaccine makers raise concerns over US panel’s shift away from hepatitis B shots for newborns
• 11:04 Kennedy advisers to vote on dropping hepatitis B vaccine recommendation for most US children
• 16:45 摩根士丹利推荐欧洲制药业投资首选
• 16:43 Morgan Stanley’s Top European Pharmaceutical Picks for Investors
• 16:30 Amicus Therapeutics (FOLD) Up 6.4% Since Last Earnings Report: Can It Continue?
• 11:09 Kennedy’s vaccine advisers to weigh hepatitis B vaccine timing in consequential policy change
• 02:14 Alector: president Kenkare-Mitra sells $46k in shares